Tag Archives: Abramson Cancer Center

February, 2017

September, 2016

  • 12 September

    Case for Liquid Biopsies Builds in Advanced Lung Cancer

    PHILADELPHA— For patients with advanced lung cancer, a non-invasive liquid biopsy may be a more effective and suitable alternative to the gold standard tissue biopsy to detect clinically relevant mutations and help guide their course of treatment, suggests a new study published this week in the journal Clinical Cancer Research …

August, 2016

April, 2016

  • 26 April

    Exelixis’ Renal Cell Carcinoma Drug Receives FDA Approval

    SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX™ (cabozantinib) tablets for the treatment of patients with advanced renal cell carcinoma (RCC) who have received prior anti-angiogenic therapy. RCC is the most common form of kidney cancer in adults. …

January, 2016